CRISPR-Cas9 Disruption of Aquaporin 1: An Alternative to Glaucoma Eye Drop Therapy?
Gespeichert in:
Veröffentlicht in: | Molecular therapy 2020-03, Vol.28 (3), p.706-708 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 708 |
---|---|
container_issue | 3 |
container_start_page | 706 |
container_title | Molecular therapy |
container_volume | 28 |
creator | Komáromy, András M. |
description | |
doi_str_mv | 10.1016/j.ymthe.2020.02.011 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7054811</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1525001620300976</els_id><sourcerecordid>2374375451</sourcerecordid><originalsourceid>FETCH-LOGICAL-c459t-892cc63617a1a1efbf334c61ea57ceec1d71cacecb79e262d2a52dad5a8bfdd13</originalsourceid><addsrcrecordid>eNp9UV1r3DAQFKWlSdP-gkLRY1_saGXLH4W2HJc0CQRSkvRZ7Mnrng7bciT54P5973LJkb7kaQd2dmaZYewziBQEFKerdNPHJaVSSJEKmQqAN-wYlFSJEDJ_e8BQHLEPIay2CFRdvGdHmRRlVQl1zO7mt1d3v2-TOYaan9ngpzFaN3DX8tnDhKPzduDwjc8GPusi-QGjXROPjl90OBnXIz_fED_zbuT3S_I4bn5-ZO9a7AJ9epon7M-v8_v5ZXJ9c3E1n10nJld1TKpaGlNkBZQICNQu2izLTQGEqjREBpoSDBoyi7ImWchGopINNgqrRds0kJ2wH3vdcVr01BgaosdOj9726DfaodX_bwa71H_dWpdC5RXsBL4-CXj3MFGIurfBUNfhQG4KWmZlnpUqVztqtqca70Lw1B5sQOhdHXqlH-vQuzq0kFo8Gnx5-eHh5jn_LeH7nkDbnNaWvA7G0mCosZ5M1I2zrxr8A7yincE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2374375451</pqid></control><display><type>article</type><title>CRISPR-Cas9 Disruption of Aquaporin 1: An Alternative to Glaucoma Eye Drop Therapy?</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Komáromy, András M.</creator><creatorcontrib>Komáromy, András M.</creatorcontrib><identifier>ISSN: 1525-0016</identifier><identifier>EISSN: 1525-0024</identifier><identifier>DOI: 10.1016/j.ymthe.2020.02.011</identifier><identifier>PMID: 32078805</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aquaporin 1 ; Ciliary Body ; CRISPR-Cas Systems ; Gene Editing ; Genetic Therapy ; Glaucoma ; Humans ; Ophthalmic Solutions</subject><ispartof>Molecular therapy, 2020-03, Vol.28 (3), p.706-708</ispartof><rights>2020 The American Society of Gene and Cell Therapy</rights><rights>2020 The American Society of Gene and Cell Therapy. 2020 The American Society of Gene and Cell Therapy</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c459t-892cc63617a1a1efbf334c61ea57ceec1d71cacecb79e262d2a52dad5a8bfdd13</citedby><cites>FETCH-LOGICAL-c459t-892cc63617a1a1efbf334c61ea57ceec1d71cacecb79e262d2a52dad5a8bfdd13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054811/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054811/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32078805$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Komáromy, András M.</creatorcontrib><title>CRISPR-Cas9 Disruption of Aquaporin 1: An Alternative to Glaucoma Eye Drop Therapy?</title><title>Molecular therapy</title><addtitle>Mol Ther</addtitle><subject>Aquaporin 1</subject><subject>Ciliary Body</subject><subject>CRISPR-Cas Systems</subject><subject>Gene Editing</subject><subject>Genetic Therapy</subject><subject>Glaucoma</subject><subject>Humans</subject><subject>Ophthalmic Solutions</subject><issn>1525-0016</issn><issn>1525-0024</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UV1r3DAQFKWlSdP-gkLRY1_saGXLH4W2HJc0CQRSkvRZ7Mnrng7bciT54P5973LJkb7kaQd2dmaZYewziBQEFKerdNPHJaVSSJEKmQqAN-wYlFSJEDJ_e8BQHLEPIay2CFRdvGdHmRRlVQl1zO7mt1d3v2-TOYaan9ngpzFaN3DX8tnDhKPzduDwjc8GPusi-QGjXROPjl90OBnXIz_fED_zbuT3S_I4bn5-ZO9a7AJ9epon7M-v8_v5ZXJ9c3E1n10nJld1TKpaGlNkBZQICNQu2izLTQGEqjREBpoSDBoyi7ImWchGopINNgqrRds0kJ2wH3vdcVr01BgaosdOj9726DfaodX_bwa71H_dWpdC5RXsBL4-CXj3MFGIurfBUNfhQG4KWmZlnpUqVztqtqca70Lw1B5sQOhdHXqlH-vQuzq0kFo8Gnx5-eHh5jn_LeH7nkDbnNaWvA7G0mCosZ5M1I2zrxr8A7yincE</recordid><startdate>20200304</startdate><enddate>20200304</enddate><creator>Komáromy, András M.</creator><general>Elsevier Inc</general><general>American Society of Gene & Cell Therapy</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200304</creationdate><title>CRISPR-Cas9 Disruption of Aquaporin 1: An Alternative to Glaucoma Eye Drop Therapy?</title><author>Komáromy, András M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c459t-892cc63617a1a1efbf334c61ea57ceec1d71cacecb79e262d2a52dad5a8bfdd13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aquaporin 1</topic><topic>Ciliary Body</topic><topic>CRISPR-Cas Systems</topic><topic>Gene Editing</topic><topic>Genetic Therapy</topic><topic>Glaucoma</topic><topic>Humans</topic><topic>Ophthalmic Solutions</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Komáromy, András M.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Molecular therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Komáromy, András M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CRISPR-Cas9 Disruption of Aquaporin 1: An Alternative to Glaucoma Eye Drop Therapy?</atitle><jtitle>Molecular therapy</jtitle><addtitle>Mol Ther</addtitle><date>2020-03-04</date><risdate>2020</risdate><volume>28</volume><issue>3</issue><spage>706</spage><epage>708</epage><pages>706-708</pages><issn>1525-0016</issn><eissn>1525-0024</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32078805</pmid><doi>10.1016/j.ymthe.2020.02.011</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1525-0016 |
ispartof | Molecular therapy, 2020-03, Vol.28 (3), p.706-708 |
issn | 1525-0016 1525-0024 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7054811 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
subjects | Aquaporin 1 Ciliary Body CRISPR-Cas Systems Gene Editing Genetic Therapy Glaucoma Humans Ophthalmic Solutions |
title | CRISPR-Cas9 Disruption of Aquaporin 1: An Alternative to Glaucoma Eye Drop Therapy? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T07%3A23%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CRISPR-Cas9%20Disruption%20of%20Aquaporin%201:%20An%20Alternative%20to%20Glaucoma%20Eye%20Drop%20Therapy?&rft.jtitle=Molecular%20therapy&rft.au=Kom%C3%A1romy,%20Andr%C3%A1s%20M.&rft.date=2020-03-04&rft.volume=28&rft.issue=3&rft.spage=706&rft.epage=708&rft.pages=706-708&rft.issn=1525-0016&rft.eissn=1525-0024&rft_id=info:doi/10.1016/j.ymthe.2020.02.011&rft_dat=%3Cproquest_pubme%3E2374375451%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2374375451&rft_id=info:pmid/32078805&rft_els_id=S1525001620300976&rfr_iscdi=true |